FDA APPROVES OVER-THE-COUNTER NALOXONE

News



- Mar 31
NEW STUDY REVEALS SHARED GENETIC MARKERS UNDERLYING SUBSTANCE USE DISORDERS
- Mar 31
SAMHSA WARNS OF GROWING THREAT FROM XYLAZINE
- Mar 31
DEA ISSUES ALERT ON RISE OF FENTANYL MIXED WITH XYLAZINE


- Mar 31
U.S.-LED GLOBAL EFFORT HAS DRAMATICALLY INCREASED NUMBER RECEIVING LIFESAVING HIV TREATMENT
- Mar 31
NALOXONE EXPANSION NOT ASSOCIATED WITH INCREASES IN ADOLESCENT HEROIN AND INJECTION DRUG USE
- Mar 31
STUDY SHOWS HIGH PREVALENCE OF BUPRENORPHINE 'SPIKING' IN URINE SCREENINGS FOR OUD PATIENTS
- Mar 24
STUDY SUGGESTS HIGH-DOSE BUPRENORPHINE IS USEFUL AMONG PATIENTS USING FENTANYL AND OTHER OPIOIDS
- Mar 24
HOUSE MEMBERS FORM BIPARTISAN FENTANYL PREVENTION CAUCUS
- Mar 24
BIPARTISAN SENATE GROUP INTRODUCES LEGISLATION TO CRACK DOWN ON XYLAZINE


- Mar 24
NEW STUDY REVEALS SHARED GENETIC MARKERS UNDERLYING SUBSTANCE USE DISORDERS
- Mar 17
APPLY FOR THREE NHSC LOAN REPAYMENT PROGRAMS WITH JUST ONE APPLICATION
- Mar 17
LAPPA RELEASES MODEL ACT ON SUBSTANCE USE DURING PREGNANCY AND FAMILY CARE PLANS


- Mar 17
LACK OF FUNDING TO FIGHT ADDICTION IN NY STATE BUDGET DRAWS CRITICISM
- Mar 17
SAMHSA SEEKING $10.8 BILLION IN FY 2024 TO BOLSTER MENTAL HEALTH AND SUBSTANCE USE SERVICES ACROSS T


- Mar 3
Recently published, The Therapeutic Community: Research and Practice by Carole Harvey


- Mar 3
TRAUMA CAUSES HIGH LEVELS OF INTERGENERATIONAL SUBSTANCE USE AMONG BLACK WOMEN
- Mar 3
ADDICTION TREATMENT MAY BE COMING TO A PHARMACY NEAR YOU
- Mar 3
FDA ACTS TO RESTRICT ILLICIT IMPORT OF XYLAZINE, ANIMAL TRANQUILIZER LINKED TO OVERDOSE DEATHS


- Mar 3
U.S. DEATHS INVOLVING METH ARE SKYROCKETING, FENTANYL A BIG FACTOR